Admittedly, though the series of DM1 and DM2 patients are well characterized about the endocrine and metabolic phenotype, the small sample size prevents to define the role of insulin resistance and hyperglycemia in regulating plasma irisin levels. This evidence concerns the gene FNDC5 and myotonic dystrophy type 1.